Company profile

VIVA! Communications


Expertise: Marketing, PR & media



Bio: VIVA! Communications is a dynamic, strategic, independent Australian health + wellness communications agency with proven results in the medical, pharmaceutical, biotech and community health sectors.

VIVA! Communications is also the exclusive Australian representative and Asia Pacific Hub Lead for GLOBALHealthPR – the largest health and science communications agency partnership worldwide.

Established in 2002, VIVA! Communications has earned an enviable reputation among the professional healthcare community and health media fraternity for delivering proactive, innovative, versatile and outcomes-driven work of the highest quality. Our specialist healthcare communication strategists have extensive experience in PR, journalism, public health, science and corporate and government relations.

Because we are not weighed down by red tape, who you meet initially is who you will work with from start to finish, to create, plan and implement your communications strategy. By combining established PR practices with emerging communication channels, VIVA! Communications is forging a new path in health + wellness communications.

If you share our passion for health + wellness communication, require strategic advice on a project, or would like some fresh ideas for your product, clinical trial or organisation, please get in touch to learn more – www.vivacommunications.com.au / + 61 2 9968 3741

RECENT AWARDS:

2018
PRIME Awards:

  • WINNER - Best Public Health Initiative - Enhancing "community immunity" through pharmacy-led flu vaccination


2017
Public Relations Institute of Australia National Golden Target Awards:

  • WINNER - PRIA NATIONAL GTA - Australia's Best Small Consultancy of the Year


Public Relations Institute of Australia NSW Golden Target Awards

  • WINNER - PRIA NSW GTA - Community Relations: Enhancing "community immunity" against flu with pharmacist-led vaccinations

  • WINNER - PRIA NSW GTA - Small Consultancy of the Year

  • HIGHLY COMMENDED- PRIA NSW GTA - Public Health: Driving volunteers into the groundbreaking Australian Genetics of Depression Study

[Total: 1    Average: 5/5]

News & Trends - Medical Technology

MedTech News - Siemens Healthineers to acquire Varian in $16.4bn deal

Siemens Healthineers to acquire Varian in $16.4bn deal

Health Industry Hub | August 5, 2020 |

MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion. Since 2012, Siemens Healthineers and Varian have […]

More


News & Trends - Pharmaceuticals

Pharma News - New anti-cancer drug for prostate cancer

New anti-cancer drug for prostate cancer

Health Industry Hub | August 5, 2020 |

Pharma News: A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis […]

More


News & Trends - Pharmaceuticals

Pharma News -

Popular high blood pressure drug linked to increased skin cancer risk

Health Industry Hub | August 5, 2020 |

Pharma News: Hydrochlorothiazide, a diuretic, is one of the most prescribed high blood pressure drugs and is used alone or […]

More


News & Trends - Pharmaceuticals

Pharma News - Australian triple therapy for COVID-19 cure and prevention

Australian triple therapy for COVID-19 cure and prevention

Health Industry Hub | August 5, 2020 |

Pharma News: The Centre for Digestive Disease (CDD) Medical Director Professor Thomas Borody says TGA and FDA approved Ivermectin, which […]

More